Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
2.
J Invest Dermatol ; 143(10): 1937-1946.e7, 2023 10.
Article in English | MEDLINE | ID: mdl-37037414

ABSTRACT

Merkel cell carcinoma (MCC) is an aggressive skin cancer for which Merkel cell polyomavirus integration and expression of viral oncogenes small T and Large T have been identified as major oncogenic determinants. Recently, a component of the PRC2 complex, the histone methyltransferase enhancer of zeste homolog 2 (EZH2) that induces H3K27 trimethylation as a repressive mark has been proposed as a potential therapeutic target in MCC. Because divergent results have been reported for the levels of EZH2 and trimethylation of lysine 27 on histone 3, we analyzed these factors in a large MCC cohort to identify the molecular determinants of EZH2 activity in MCC and to establish MCC cell lines' sensitivity to EZH2 inhibitors. Immunohistochemical expression of EZH2 was observed in 92% of MCC tumors (156 of 170), with higher expression levels in virus-positive than virus-negative tumors (P = 0.026). For the latter, we showed overexpression of EZHIP, a negative regulator of the PRC2 complex. In vitro, ectopic expression of the large T antigen in fibroblasts led to the induction of EZH2 expression, whereas the knockdown of T antigens in MCC cell lines resulted in decreased EZH2 expression. EZH2 inhibition led to selective cytotoxicity on virus-positive MCC cell lines. This study highlights the distinct mechanisms of EZH2 induction between virus-negative and -positive MCC.


Subject(s)
Carcinoma, Merkel Cell , Merkel cell polyomavirus , Skin Neoplasms , Humans , Carcinoma, Merkel Cell/pathology , Histones/metabolism , Enhancer of Zeste Homolog 2 Protein/genetics , Enhancer of Zeste Homolog 2 Protein/metabolism , Skin Neoplasms/pathology , Merkel cell polyomavirus/genetics , Antigens, Viral, Tumor/genetics , Antigens, Viral, Tumor/metabolism
3.
J Pathol ; 257(1): 96-108, 2022 05.
Article in English | MEDLINE | ID: mdl-35049062

ABSTRACT

We report 21 cases of trichogerminoma harbouring previously undescribed FOXK1::GRHL1/2 or GPS2::GRHL1/2/3 in-frame fusion transcripts. Microscopic examination of a preliminary set of five cases revealed well-delimitated tumours located in the dermis with frequent extension to the subcutaneous tissue. Tumours presented a massive and nodular architecture and consisted of a proliferation of basaloid cells. A biphasic pattern sometime resulting in tumour cell nests ('cell balls') was present. Immunohistochemistry demonstrated the expression of cytokeratins (CKs) 15, 17, and PHLDA1. In addition, numerous CK20-positive Merkel cells were detected. RNA sequencing (RNA-seq) revealed a FOXK1::GRHL1 chimeric transcript in three cases and a FOXK1::GRHL2 fusion in two cases. In a second series for validation (n = 88), FOXK1::GRHL1/2 fusion transcripts were detected by RT-qPCR or FISH in an additional 12 trichogerminomas and not in any other follicular tumour entities or basal cell carcinoma cases (n = 66). Additional RNA-seq analysis in trichogerminoma cases without detected FOXK1::GRHL1/2 rearrangements revealed GPS2::GRHL1 fusion transcripts in two cases, GPS2::GRHL2 in one case, and GPS2::GRHL3 fusion transcript in one case. Therefore, our study strongly suggests that GRHL1/2/3 gene rearrangements might represent the oncogenic driver in trichogerminoma, a subset of follicular tumours characterized by immature features and numerous Merkel cells. © 2022 The Pathological Society of Great Britain and Ireland.


Subject(s)
Skin Neoplasms , Forkhead Transcription Factors/genetics , Gene Rearrangement , Humans , Immunohistochemistry , Skin Neoplasms/genetics , Skin Neoplasms/pathology , United Kingdom
4.
Hip Int ; 32(1): 87-93, 2022 Jan.
Article in English | MEDLINE | ID: mdl-32538176

ABSTRACT

AIMS: To evaluate the accuracy of intraoperative frozen section histopathology for diagnosing periprosthetic joint infection (PJI) during hip revision surgery, both for patients with and without recent trauma to the hip. PATIENTS AND METHODS: The study included all revision total hip replacement procedures where intraoperative frozen section histopathology had been used for the evaluation of infection in a single institution between 2008 and 2015. Musculoskeletal Infection Society criteria were used to define infection. 210 hips were included for evaluation. Prior to revision surgery, 36 hips had a dislocation or a periprosthetic fracture (group A), and 174 did not (group B). RESULTS: The prevalence of infection was 14.3% (5.6% in group A and 16.1% in group B). Using Feldman criteria, the sensitivity of histopathology was 50.0%, specificity 47.1%, positive predictive value 5.3% and negative predictive value 94.1% in group A. The sensitivity of frozen section histopathology was 75.0%, specificity 96.5%, positive predictive value 85% and negative predictive value 95.3% in group B. CONCLUSIONS: Intraoperative frozen section histopathology is reliable for the diagnosis of PJI if no dislocation or periprosthetic fracture has occurred prior to hip revision surgery.


Subject(s)
Arthroplasty, Replacement, Hip , Arthroplasty, Replacement, Knee , Periprosthetic Fractures , Prosthesis-Related Infections , Arthroplasty, Replacement, Hip/adverse effects , Frozen Sections , Humans , Periprosthetic Fractures/diagnostic imaging , Periprosthetic Fractures/etiology , Prosthesis-Related Infections/diagnosis , Prosthesis-Related Infections/surgery , Reoperation , Retrospective Studies , Sensitivity and Specificity
5.
BMJ Case Rep ; 13(1)2020 Jan 23.
Article in English | MEDLINE | ID: mdl-31980473

ABSTRACT

Dialysis-related amyloidosis (DRA) or ß2microglobulin (ß2m)-amyloidosis is a disorder caused by the inability to clear a protein called ß2m in patients with chronic kidney disease. It results in deposition of ß2m as amyloid fibrils, most commonly in bones and joints. Infrequently, visceral organs may be involved. With modern high-flux haemodialysis, DRA has become a rare disease, yet it may occur. We present a case of DRA in an 86-year-old woman. This case is particularly notable for its rare presentation as chronic intestinal pseudo-obstruction. It is of paramount importance to recognise this entity in order to reduce delay in treatment and avoid patients being frustrated not getting a diagnosis.


Subject(s)
Amyloidosis/etiology , Intestinal Pseudo-Obstruction/etiology , Renal Dialysis/adverse effects , Renal Insufficiency, Chronic/complications , beta 2-Microglobulin/metabolism , Aged, 80 and over , Amyloid/metabolism , Chronic Disease , Female , Humans
6.
Exp Mol Pathol ; 99(3): 485-91, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26407762

ABSTRACT

The advent of BRAF-targeted therapies led to increased survival in patients with metastatic melanomas harboring a BRAF V600 mutation (implicated in 46-48% of malignant melanomas). The Idylla(™) System (Idylla(™)), i.e., the real-time-PCR-based Idylla(™) BRAF Mutation Test performed on the fully-automated Idylla(™) platform, enables detection of the most frequent BRAF V600 mutations (V600E/E2/D, V600K/R/M) in tumor material within approximately 90 min and with 1% detection limit. Idylla(™) performance was determined in a multi-center study by analyzing BRAF mutational status of 148 archival formalin-fixed paraffin-embedded (FFPE) tumor samples from malignant melanoma patients, and comparing Idylla(™) results with assessments made by commercial or in-house routine diagnostic methods. Of the 148 samples analyzed, Idylla(™) initially recorded 7 insufficient DNA input calls and 15 results discordant with routine method results. Further analysis learned that the quality of 8 samples was insufficient for Idylla(™) testing, 1 sample had an invalid routine test result, and Idylla(™) results were confirmed in 10 samples. Hence, Idylla(™) identified all mutations present, including 7 not identified by routine methods. Idylla(™) enables fully automated BRAF V600 testing directly on FFPE tumor tissue with increased sensitivity, ease-of-use, and much shorter turnaround time compared to existing diagnostic tests, making it a tool for rapid, simple and highly reliable analysis of therapeutically relevant BRAF mutations, in particular for diagnostic units without molecular expertise and infrastructure.


Subject(s)
Formaldehyde , Melanoma/genetics , Mutation , Proto-Oncogene Proteins B-raf/genetics , Real-Time Polymerase Chain Reaction/methods , Skin Neoplasms/genetics , DNA Mutational Analysis/methods , Humans , Melanoma/diagnosis , Mutation/genetics , Paraffin Embedding/methods , Skin Neoplasms/diagnosis , Skin Neoplasms/pathology , Melanoma, Cutaneous Malignant
8.
Virchows Arch ; 446(1): 64-7, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15660283

ABSTRACT

Rhabdomyosarcomas are classified into three well-defined categories: embryonal, alveolar and pleomorphic rhabdomyosarcoma. Recently, seven cases of an unusual adult type of rhabdomyosarcoma with a prominent hyaline sclerosis have been described. We report the hitherto unreported cytogenetic changes of an adult sclerosing rhabdomyosarcoma. A 79-year-old woman underwent an amputation for a rapidly growing soft tissue mass in the anterior compartment of the right lower leg. The tumor infiltrated the tibia. On histology, a fascicular spindle to round cell proliferation, embedded in a prominent hyaline matrix, was seen. Immunohistochemistry showed focal desmin, myogenin and MyOD1 expression, and electron microscopy revealed Z-band material. Cytogenetic analysis disclosed a 44-49,XX,+del(1)(p22)[2],+11,+16[5],+18[12],+21[3],-22 [cp13] karyotype. Using fluorescent in situ hybridization (FISH) analysis, the tumor cells were negative for FOXO1A-disrupting translocations specific for alveolar rhabdomyosarcoma. The chromosomal composition of malignant cells resembled the pattern of numerical changes frequently observed in embryonal rhabdomyosarcoma, suggesting a close relationship of an adult sclerosing rhabdomyosarcoma with this entity.


Subject(s)
Rhabdomyosarcoma, Embryonal/genetics , Rhabdomyosarcoma/genetics , Translocation, Genetic , Aged , Female , Humans , Immunohistochemistry , Rhabdomyosarcoma/classification , Rhabdomyosarcoma/pathology , Rhabdomyosarcoma, Embryonal/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...